European Heart Journal. Case Reports
Overview
European Heart Journal. Case Reports is a scientific journal, published by Oxford University Press since 2017 in English. The journal's country of origin is United Kingdom and its primary focus area is cardiology & vascular diseases.
Details
Details
Abbr.
Eur Heart J Case Rep
Publisher
Oxford University Press
Start
2017
End
Continuing
e-ISSN
2514-2119
Country
United Kingdom
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 13168
16
SJR / Ranks: 11694
312
CiteScore / Ranks: 12453
1.20
Recent Articles
11.
Yamamoto H, Ohta Y, Ikeda Y, Beppu S
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf104.
PMID: 40061109
Background: Calcified amorphous tumour (CAT) is a rare lesion that forms at various sites of the heart, including the mitral annulus. Since it is a systemic embolic source, it often...
12.
Van den Bosch L, Vanclooster P, Van Offenwert J, Teuwen L, Franssen C
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf058.
PMID: 40061108
Background: Disseminated infection is a severe condition in immunocompromised patients. Mortality secondary to cardiac infection remains high. Case Summary: We present a case of a 45-year-old female breast cancer patient...
13.
Hua W, Huang H, Chen X, Pan X
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf069.
PMID: 40061107
No abstract available.
14.
Hirose S, Enta Y, Miyasaka M, Tada N
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf090.
PMID: 40061106
No abstract available.
15.
Ahmad Y, Abdallah T, AlAli M, Adeeb M, Alhammoud M
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf080.
PMID: 40061105
Background: Primary cardiac tumours are rare, with an incidence ranging from 0.001% to 0.03%. Among these, sarcomas constitute the majority of malignant cases, with malignant fibrous histiocytoma (MFH) being one...
16.
Kinugawa M, Nishimoto Y, Adachi S, Hayashi T
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf088.
PMID: 40061104
No abstract available.
17.
Kalkan A, Pennig L, Pfister R, Cornely O, Stemler J
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf044.
PMID: 40061103
Background: Midostaurin is a multikinase inhibitor for the treatment of Fms-like tyrosine 3 ()-mutated acute myeloid leukaemia (AML). Cardiac adverse events like QTc-prolongation, pericardial effusion, and congestive heart failure have...
18.
Yamanaka T, Higashitani M, Ichinohe Y, Fukatsu T, Kunihara T
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf076.
PMID: 40061102
Background: It has been reported that mechanical damage occurs when regurgitant flow from aortic regurgitation (AR) directly impinges on the anterior mitral valve leaflet (AML). However, only a few cases...
19.
Jubeh R, Asher E, Dvir D, Glikson M, Bruoha S
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf089.
PMID: 40061101
Background: 'Simultaneous CardioFlow optimization' represents an innovative technique that effectively enhances post-pacing haemodynamic recovery during transcatheter aortic valve replacement. This technique was applied in two high-risk patients presenting with severe...
20.
Ichikawa-Ogura S, Mochizuki Y, Toyosaki E, Fukuoka H, Shinke T
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf098.
PMID: 40061100
Background: Libman-Sacks endocarditis), a non-bacterial thrombotic endocarditis (NBTE) linked to systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), typically causes valve regurgitation and embolism but can rarely mimic rheumatic mitral...